Skip to Content
Merck
  • Scaffolding viral protein NC nucleates phase separation of the HIV-1 biomolecular condensate.

Scaffolding viral protein NC nucleates phase separation of the HIV-1 biomolecular condensate.

Cell reports (2022-08-25)
Anne Monette, Meijuan Niu, Maya Nijhoff Asser, Robert J Gorelick, Andrew J Mouland
ABSTRACT

Membraneless biomolecular condensates (BMCs) contribute to the replication of a growing number of viruses but remain to be functionally characterized. Previously, we demonstrated that pan-retroviral nucleocapsid (NC) proteins phase separated into condensates regulating virus assembly. Here we discover that intrinsically disordered human immunodeficiency virus-type 1 (HIV-1) core proteins condense with the viral genomic RNA (vRNA) to assemble as BMCs attaining a geometry characteristic of viral reverse transcription complexes. We explore the predisposition, mechanisms, and pharmacologic sensitivity of HIV-1 core BMCs in living cells. HIV-1 vRNA-interacting NC condensates were found to be scaffolds onto which client capsid, reverse transcriptase, and integrase condensates assemble. HIV-1 core BMCs exhibit fundamental characteristics of BMCs and are drug-sensitive. Lastly, protease-mediated maturation of Gag and Gag-Pol precursor proteins yield abundant and visible BMCs in cells. This study redefines HIV-1 core components as fluid BMCs and advances our understanding of the nature of viral cores during ingress.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
RNase A solution
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Nocodazole Ready Made Solution, 5 mg/mL, DMSO solution
SKU
Pack Size
Availability
Price
Quantity